Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Acquisitions (2020 - 2023)

LifeStance Health (LFST) has disclosed Acquisitions for 4 consecutive years, with $19.8 million as the latest value for Q1 2023.

  • On a quarterly basis, Acquisitions fell 13.62% to $19.8 million in Q1 2023 year-over-year; TTM through Dec 2023 was $19.8 million, a 67.08% decrease, with the full-year FY2023 number at $19.8 million, down 67.08% from a year prior.
  • Acquisitions was $19.8 million for Q1 2023 at LifeStance Health, roughly flat from $19.9 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $40.9 million in Q4 2021 to a low of $754000.0 in Q1 2021.
  • A 4-year average of $19.3 million and a median of $19.9 million in 2022 define the central range for Acquisitions.
  • Biggest YoY gain for Acquisitions was 2943.1% in 2022; the steepest drop was 51.3% in 2022.
  • LifeStance Health's Acquisitions stood at $30.1 million in 2020, then surged by 35.83% to $40.9 million in 2021, then tumbled by 51.3% to $19.9 million in 2022, then fell by 0.46% to $19.8 million in 2023.
  • Per Business Quant, the three most recent readings for LFST's Acquisitions are $19.8 million (Q1 2023), $19.9 million (Q4 2022), and $5.2 million (Q3 2022).